Transient regression and fluctuation of bilateral adrenal masses: a rare presentation of primary adrenal lymphoma
DOI:
https://doi.org/10.18203/2349-2902.isj20221418Keywords:
Primary adrenal lymphoma, Adrenal mass, Extra-nodal, DLBCLAbstract
Primary adrenal lymphoma is a rare form of extra-nodal lymphoma which scarcely reported in the literature reviews. We describe such a case who presented with fluctuation in the sizes of bilateral adrenal masses. A 61-year-old lady who presented with a history of right flank discomfort with no other associated symptoms. Initial imaging showed bilateral adrenal masses. She was evaluated and excluded for possibilities of pheochromocytoma, cortical carcinoma and secondary tumour deposits. Interestingly, a consecutive of contrast-enhanced computed tomography images showed transient regression and fluctuation of bilateral adrenal masses, which making the diagnosis became more challenging. A confirmatory histological diagnosis was obtained via imaging-guided biopsy which revealed diffuse large B cell lymphoma. Unfortunately, the patient was reluctant to receive chemotherapy and eventually lost to follow-up. Diagnosing a primary adrenal lymphoma can be challenging due to its rarity and requires high index of suspicion for timely diagnosis and treatment.
References
Kerkhofs TM, Roumen RM, Demeyere TB. Adrenal tumors with unexpected outcome: a review of the literature. Int J Endocrinol. 2015;710514.
Rashidi A, Fisher SI. Primary adrenal lymphoma: a systematic review. Ann Hematol 2013; 92:1583-93.
Zhang Z, Wang L, Chen J, et al. Clinical analysis of adrenal lesions larger than 5 cm in diameter (an analysis of 251 cases). World J Surg Onc. 2019;17:220.
Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;29:252-60.
Mozos A, Ye H, Chuang WY. Most primary adrenal lymphoma are diffuse large B-cell lymphomas with non-germinal center B-cell phenotype, BCL6 gene rearrangement and poor prognosis. Mod Pathol. 2009;22:1210-1270.
Laurent C, Casasnovas O, Martin L. Adrenal lymphoma: presentation, management and prognosis. QJM 2017;110:103-9.
Yang L, Zhang M, Zhao S. Correlations between MDCT features and clinicopathological findings of primary adrenal lymphoma. Eur J Radiol. 2019;113:110-5.
Zhou L, Peng W, Wang C. Primary adrenal lymphoma: radiological; pathological, clinical correlation. Eur J Radiol. 2012;81:401-5.
Muraoka Y, Iwama S, Arima H. Normalization of Bilateral Adrenal Gland Enlargement after Treatment for Cryptococcosis. Case Rep Endocrinol. 2017;2017:1543149.
Bouchikhi AA, Tazi MF, Amiroune D. Primary Bilateral Non- Hodgkin’s Lymphoma of the Adrenal Gland: a case report. Case Rep Urol. 2012;2012:325675.
Singh A, Udupa K, Madhyastha SP. Bilateral primary adrenal lymphoma successfully treated with non-CHOP chemotherapy regimen. BMJ Case Rep. 2018;2018:bcr-2017-223078.
Zaman S, Boharoon H, Khalid N, Marks S. The vanishing adrenal glands: A transient regression of adrenal lymphoma after a single dose of 1 mg dexamethasone. AACE Clinical Case Reports. 2020.
Choi WW, Weisenburger DD, Greiner TC, Piris MA, Banham AH, Delabie J et al. A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res. 2009;15:5494-502.
Coiffier B, Lepage E, Brière J. CHOP chemotherapy plus rituximab compared with chop alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:235-42.
Kim YR, Kim JS, Min YH, Hyunyoon D, Shin HJ, Mun YC et al. Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL). J Hematol Oncol. 2012;5:49.
